FDA approves first biosimilar for cancer

The US Food and Drug Administration (FDA) has  approved a biosimilar of Avastin (bevacizumab) for multiple cancer indications.
Source: The Pharmaceutical Journal - Category: Drugs & Pharmacology Source Type: research